SCHEMBL469197

SCHEMBL469197

CC[C@H](C)c1nc(C2CC2)no1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.40
IDH1 O75874 3/20 0.36
HCRTR1 O43613 3/20 0.36
HCRTR2 O43614 3/20 0.36
MTNR1A P48039 1/20 0.35
MTNR1B P49286 1/20 0.35
DGKZ Q13574 3/20 0.33
OPRK1 P41145 2/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA9 Q16790 1/20 0.32
CASP3 P42574 1/20 0.32
SENP7 Q9BQF6 1/20 0.32
SENP6 Q9GZR1 1/20 0.32
FABP4 P15090 1/20 0.32
FABP5 Q01469 1/20 0.32
TP53 P04637 2/20 0.32
MDM2 Q00987 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13827635 1.00 POLB (0.40) POLBIDH1HCRTR1HCRTR2MTNR1A
SCHEMBL22930811 0.86 POLB (0.39) POLBIDH1HCRTR1HCRTR2MTNR1A
SCHEMBL22930730 0.83 POLB (0.37) POLBIDH1HCRTR1HCRTR2DGKZ
SCHEMBL25017716 0.82 GAA (0.36) POLBIDH1HCRTR1HCRTR2DGKZ
SCHEMBL12299867 0.81 HCRTR1 (0.43) POLBIDH1HCRTR1HCRTR2CA1
SCHEMBL24092054 0.80 POLB (0.38) POLBIDH1HCRTR1HCRTR2DGKZ
SCHEMBL24092032 0.80 POLB (0.35) POLBIDH1HCRTR1HCRTR2DGKZ
SCHEMBL18994469 0.78 IDH1 (0.37) POLBIDH1HCRTR1HCRTR2MTNR1A
SCHEMBL12904903 0.77 POLB (0.34) POLBIDH1MTNR1AMTNR1BDGKZ
Hydrochloric Acid SCHEMBL20559927 0.76 IDH1 (0.36) POLBIDH1HCRTR1HCRTR2OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11198687-B2 Heteroaryl allosteric modulators of nicotinic acetylcholine receptors MERCK SHARP & DOHME CORP. (US) 2021-12-14 US disclosed
US-8247401-B2 P2X3 receptor antagonists for treatment of pain MERCK SHARP & DOHME CORP. (US) 2012-08-21 US disclosed
US-20120064181-A1 P2X3 Receptor Antagonists for Treatment of Pain MERCK SHARP & DOHME LLC 2012-03-15 US disclosed
US-20100266714-A1 P2X3 RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN MERCK SHARP & DOHME LLC 2010-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11198687-B2 Heteroaryl allosteric modulators of nicotinic acetylcholine receptors CHRNA7, CHRNA5, CHRNA2 POLB 2928/4885IDH1 3425/4885HCRTR1 366/4885
US-20100266714-A1 P2X3 RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN P2RX3, P2RX1, P2RX2 POLB 4302/4885IDH1 4799/4885HCRTR1 309/4885
US-20120064181-A1 P2X3 Receptor Antagonists for Treatment of Pain P2RX3, P2RX1, P2RX2 POLB 4302/4885IDH1 4799/4885HCRTR1 309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.